Sun Pharma
M-cap of top seven companies decline by Rs 45,963 cr
The combined market valuation of top seven companies declined by Rs 45,962.77 crore last week with IT majors -- Infosys and TCS -- taking the maximum hit.
Sun Pharma enters into derma segment
The company will co-promote Suncros brand across prescription and consumer channels to drive growth Sun Pharma will focus on dermatology as the fourth engine of growth for its OTC business. As part of this growth strategy, th
Sun Pharma announces divestment of US manufacturing units
Divests two units to Frontida BioPharm
Sun Pharma sells two US-based plants to Frontida BioPharm
Drug major Sun Pharmaceutical Industries has sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm Inc for an undisclosed amount.
Sun’s problems to linger on for 2-3 quarters: Jefferies
Headwinds plaguing the country's largest drug-maker Sun Pharmaceutical will continue for next two-three quarters owing to pricing pressures and regulatory issues dogging its Halol plant, says a report.
Sun Pharma revenue growth guidance at 8-10 pc for FY’17
Sun Pharma also said that its board has decided to evaluate a proposal for buyback of equity shares and will hold a meeting on June 23 for the purpose.
Sun Pharma shares fall 6% on weak sales guidance
Sun Pharmaceutical Industries shares plunged nearly 6 per cent in late morning trade on Tuesday after the pharma company posted a weaker-than expected annual sales outlook as it grappled with increased competition in the Unit
Sun Pharma Q4 profit at Rs 1,713.69 cr
Country's largest drug maker Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,713.69 crore for the fourth quarter ended March 31, 2016.
M-cap of top 10 companies swells by Rs 98,598 cr, ITC biggest gainer
Driven by a sharp rally in the stock market last week, the combined market valuation of top- 10 most valued Indian companies soared by a whopping Rs 98,598 crore, with ITC emerging as the biggest mover.
Sun Pharma shares surge over 5% on termination of transition pact with Daiichi
Sun Pharma shares rallied after it said that the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.
Sun Pharma launches mobile app for asthma patients
RespiTrack seeks to enable doctors to track treatment progress of their patients and increase compliance to medication
Nine of top 10 bluechip companies lose Rs 47,932 cr in market cap
The combined market valuation of nine of the top 10 most valued Indian companies diminished by Rs 47,932.59 crore last week, with IT major TCS taking the biggest hit.
